Electrochemical cell and its use for the separation and the
electrochemical extraction of oxygen
    11.
    发明授权
    Electrochemical cell and its use for the separation and the electrochemical extraction of oxygen 失效
    电化学电池及其用于分离和电化学提取的氧气

    公开(公告)号:US5582710A

    公开(公告)日:1996-12-10

    申请号:US244034

    申请日:1994-05-16

    摘要: The present invention relates to an electrochemical cell comprising a solid electrolyte conductive for O.sup.2- anions in contact with an anode and a cathode of identical or different composition, the electrolyte solid being comprised of a composition derived from Bi.sub.4 V.sub.2 O.sub.11 of which at least one of the cationic constituent elements is substituted by at least one substituting element chosen such that the gamma phase structural type of Bi.sub.4 V.sub.2 O.sub.11 is maintained, as well as the equilibrium of charges, at least one of the anode or the cathode including two parts, a first part being of a mixed electronic and ionic conductive material in contact with the solid electrolyte, the second part being an electronic conductive material superposed on the first part. The invention equally relates to the use of the electrochemical cell with a view towards the separation or the extraction of oxygen.

    摘要翻译: PCT No.PCT / FR93 / 00872 Sec。 371日期1994年5月16日 102(e)日期1994年5月16日PCT提交1992年9月13日PCT公布。 出版物WO94 / 06545 日期:1994年3月31日本发明涉及一种电化学电池,其包含用于与阳极和阴极相接触或相同或不同组成的阴离子导电的固体电解质,电解质固体由衍生自Bi4V2O11的组合物组成, 阳离子组成元素中的至少一个被至少一个选择为使得维持Bi4V2O11的γ相结构类型以及电荷的平衡的取代元素所取代,阳极或阴极中的至少一个包括两个部分,一个 第一部分是与固体电解质接触的混合电子和离子导电材料,第二部分是重叠在第一部分上的电子导电材料。 本发明同样涉及电化学电池用于分离或提取氧气的用途。

    Nitric oxide carriers based on polyazamacrocycle complexes
    17.
    发明授权
    Nitric oxide carriers based on polyazamacrocycle complexes 失效
    基于多氮杂环络合物的一氧化氮载体

    公开(公告)号:US06310202B1

    公开(公告)日:2001-10-30

    申请号:US09423363

    申请日:2000-01-11

    IPC分类号: C07D25502

    CPC分类号: C07F15/045 C07F15/025

    摘要: Novel compounds capable of carrying and releasing nitrogen oxide (NO) in a biological medium, their use for implementing a therapeutic treatment method or a diagnostic method applied to a human or animal body, and for making medicines useful for treating or preventing disorders affecting the human or animal cardiovascular, nervous, immune, renal or pulmonary system, specifically, an organometallic complex of nitrogen oxide, wherein the cationic part is of the formula (I) in which x=0 or 1; x′=2 or 3; y=0, 2 or 3; z=0 or 1; with the condition that, if y=0 (or z=0) then z=0 (or y=0; respectively); R is a group chosen from the group formed by: a hydrogen atom, —(CH2)2COOH and R1, R2, R3 and R4 are groups chosen from the group formed by: a hydrogen atom and alkyl groups comprising from 1 to 4 carbon atoms; and M2+ is a divalent cation Fe++ or Co++.

    摘要翻译: 能够在生物培养基中携带和释放氮氧化物(NO)的新型化合物,其用于实施治疗方法或应用于人体或动物体的诊断方法,以及用于制备治疗或预防影响人类的病症的药物 或动物心血管,神经,免疫,肾或肺系统,特别是氮氧化物的有机金属络合物,其中阳离子部分为式(I),其中x = 0或1; x'= 2或3; y = 0 2或3; z = 0或1;条件是,如果y = 0(或z = 0),则z = 0(或分别为y = 0); R为选自以下的基团: 氢原子, - (CH 2)2 COOH和R 1,R 2,R 3和R 4是选自由氢原子和含有1至4个碳原子的烷基形成的基团; 和M2 +是二价阳离子Fe ++或Co ++。